Use this URL to cite or link to this record in EThOS: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.782373
Title: Investigating medulloblastoma metabolism for better diagnosis and treatment
Author: Munford, Haydn
ISNI:       0000 0004 7967 9780
Awarding Body: University of Birmingham
Current Institution: University of Birmingham
Date of Award: 2019
Availability of Full Text:
Access from EThOS:
Access from Institution:
Abstract:
Cancer cells are able to reprogram their metabolism in order to supply biosynthetic and bioenergetic demands of rapid proliferation. Glutamine is required by most cancers in significant quantities, as it serves as a major anabolic carbon and nitrogen source for synthesis of macromolecules, a source of high energy electrons for ATP production and the regulation of ROS homeostasis via glutamate through the synthesis of glutathione. The metabolism of glutamine in Medulloblastoma (MB) - the most common high grade childhood tumour - is largely unknown. Using publically available databases of MB gene expression, we observed that genes associated with glutamine metabolism were prognostic in MB patients. Furthermore, employing a combination of analytical approaches to study metabolism, we show the importance of glutamine catabolism in MB cell lines. Finally, we investigated the effect of pharmacological manipulation of glutamine metabolism and observed that inhibition of glutaminase 1 (GLS1) - the enzyme responsible for glutamate biosynthesis - can increase cisplatin and irradiation cytotoxicity. Taken together our data suggests that understanding glutamine metabolic pathways may generate prognostic bio-markers of survival and may serve to improve current therapies.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.782373  DOI: Not available
Keywords: Q Science (General)
Share: